Objective: To verify the association between cognitive decline, socioeconomic factors, and cardiovascular risk in older adults with Alzheimer's disease. Method: A cross-sectional study was carried out with 75 older adults with Alzheimer's disease. Pulse pressure, cardiovascular risk, Mini-Mental State Examination, Mini-Nutritional Assessment, and biochemical tests were performed. Results: Ninety-two percent of patients had cognitive decline, with an average of three years of schooling. There was a predominance of women (62.3%) and older adults with two or more comorbidities (62.3%). Most participants had arterial hypertension (65.2%), had elevated pulse pressure during the examination (85%), were overweight (49%), and were at nutritional risk (78%). The daily average of antihypertensive drugs was 2, and angiotensin receptor blockers were the most used drugs. Conclusion: The population studied had an increased cardiovascular risk. The nursing consultation was important for recognizing clinical data, such as cognitive decline, cardiovascular risk, nutritional risk, and altered biochemical results.
de Heus RAA, Olde Rikkert MGM, Tully PJ, Lawlor BA, Claassen JAHR, NILVAD Study Group. Blood pressure variability and progression of clinical Alzheimer disease. Hypertension. 2019;74(5):1172-80. http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13664. PMid:31542965.
Silva MVF, Loures CMG, Alves LCV, de Souza LC, Borges KBG, Carvalho MDG. Alzheimer’s disease: risk factors and potentially protective measures. J Biomed Sci. 2019;26(33):33. http://dx.doi.org/10.1186/s12929-019-0524-y. PMid:31072403.
Scheyer O, Rahman A, Hristov H, Berkowitz C, Isaacson RS, Diaz Brinton R, et al. Female sex and Alzheimer’s risk: the menopause connection. J Prev Alzheimers Dis. 2018;5(4):225-30. http://dx.doi.org/10.14283/jpad.2018.34. PMid:30298180.
Pelazza BB, Ferreira SR Fo. Comparison between central and brachial blood pressure in hypertensive elderly women and men. Int J Hypertens. 2017;2017:e6265826. http://dx.doi.org/10.1155/2017/6265823.
Barroso WKS, Rodrigues CIS, Bortolotto LA, Mota-Gomes MA, Brandão AA, Feitosa ADM, et al. Diretrizes Brasileiras de Hipertensão Arterial–2020. Arq Bras Cardiol. 2021;116(3):516-658. http://dx.doi.org/10.36660/abc.20201238. PMid:33909761.
Niiranen TJ, Kalesan B, Mitchell GF, Vasan RS. Relative contributions of pulse pressure and arterial stiffness to cardiovascular disease: the framingham heart study. Hypertension. 2019;73(3):712-7. http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12289. PMid:30661478.
van Middelaar T, van Dalen JW, van Gool WA, van den Born BJH, van Vught LA, Moll van Charante EP, et al. Visit-to-visit blood pressure variability and the risk of dementia in older people. J Alzheimers Dis. 2018;62(2):727-35. http://dx.doi.org/10.3233/JAD-170757. PMid:29480175.
Brasil. Ministério da Saúde. Envelhecimento e saúde da pessoa idosa [Internet]. Brasília: Ministério da Saúde; 2006. (Cadernos de Atenção Básica; 19). [cited 2021 Oct 8]. Available from: http://126.96.36.199/dab/docs/publicacoes/cadernos_ab/abcad19.pdf
Oliveira MR, Almeida PC, Moreira TMM, Torres RAM. Nursing care systematization: perceptions and knowledge of the Brazilian nursing. Rev Bras Enferm. 2019;72(6):1625-31. http://dx.doi.org/10.1590/0034-7167-2018-0606. PMid:31644743.
Barros M, Zamberlan C, Gehlen MH, Rosa PH, Ilha S. Awareness raising workshop for nursing students on the elderly with Alzheimer’s disease: contributions to education. Rev Bras Enferm. 2020;73(Suppl 3):e20190021. http://dx.doi.org/10.1590/0034-7167-2019-0021. PMid:32696903.
Brasil. Ministério da Saúde. Vigilância alimentar e nutricional – Sisvan: orientações básicas para a coleta, processamento, análise de dados e informação em serviços de saúde [Internet]. Brasília: Ministério da Saúde; 2004 [cited 2022 Feb 24]. Available from: http://tabnet.datasus.gov.br/cgi-win/SISVAN/CNV/notas_sisvan.html#:~:text=Valores%20de%20IMC%20menor%20ou,%2C0%3A%20idoso%20com%20sobrepeso
Ferreira JDL, Soares MJGO, Lima CLJ, Ferreira TMC, Oliveira PS, Silva MA. Evaluación nutricional por el Mini Nutritional Assessment: una herramienta para las enfermeras. Enferm Glob. 2018;17(3):267-305. http://dx.doi.org/10.6018/eglobal.17.3.290251.
Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, et al. Evidence-based prevention of Alzheimer’s disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials. J Neurol Neurosurg Psychiatry. 2020;91(11):1201-9. https://doi.org/10.1136/jnnp-2019-321913. PMID: 32690803.
Roman MJ, Devereux RB, Kizer JR, Okin PM, Lee ET, Wang W, et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study. J Am Coll Cardiol. 2009;54(18):1730-4. http://dx.doi.org/10.1016/j.jacc.2009. 05.070. PMid:19850215.
Li X, Leng S, Song D. Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment. Clin Interv Aging. 2015;10:549-60. http://dx.doi.org/10.2147/CIA.S74042. PMid:25792818.
Profenno LA, Porsteinsson AP, Faraone SV. Meta-analysis of Alzheimer’s disease risk with obesity, diabetes, and related disorders. Biol Psychiatry. 2010;67(6):505-12. http://dx.doi.org/10.1016/j.biopsych.2009.02.013. PMid:19358976.
Qu Y, Hu HY, Ou YN, Shen XN, Xu W, Wang ZT, et al. Association of body mass index with risk of cognitive impairment and dementia: a systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev. 2020;115:189-98. http://dx.doi.org/10.1016/j.neubiorev.2020.05.012. PMid:32479774.
Smith PJ, Blumenthal JA. Diet and neurocognition: review of evidence and methodological considerations. Curr Aging Sci. 2010;3(1):57-66. http://dx.doi.org/10.2174/1874609811003010057.
Hagström E, Kilander L, Nylander R, Larsson EM, Michaëlsson K, Melhus H, et al. Plasma parathyroid hormone is associated with vascular dementia and cerebral hyperintensities in two community-based cohorts. J Clin Endocrinol Metab. 2014;99(11):4181-9. http://dx.doi.org/10.1210/jc.2014-1736. PMid:25140397.
Larsson SC, Traylor M, Markus HS, Michaëlsson K. Serum parathyroid hormone, 25-hydroxyvitamin D, and risk of Alzheimer’s disease: a Mendelian randomization study. Nutrients. 2018;10(9):1243. http://dx.doi.org/10.3390/nu10091243. PMid:30200567.
Watanabe Y, Hirao Y, Kasuga K, Tokutake T, Kitamura K, Niida S, et al. Urinary apolipoprotein c3 is a potential biomarker for alzheimer’s disease. Dement Geriatr Cogn Dis Extra. 2020;10(3):94-104. http://dx.doi.org/10.1159/000509561. PMid:33082773.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2022 Array